Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 26 Pain, Postoperative 17 Neoplasms 13 Lung Neoplasms 12 Brain Neoplasms 12 Depression 7 Carcinoma, Hepatocellular 7 Pain 6 Colonic Neoplasms 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Prostatic Neoplasms 5 Leiomyoma 5 Head and Neck Neoplasms 5 Agnosia 5 Ovarian Neoplasms 4 Multiple Myeloma 4 Delirium 4 Colorectal Neoplasms 4 Anxiety Disorders 4 Supratentorial Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Myofibroma 3 Lymphoma 3 Hemorrhage 3 Fatigue 3 Emergence Delirium 3 Chronic Pain 3 Carcinoma, Non-Small-Cell Lung 3

Interventions

Tomography, X-Ray Computed 2 Serum Albumin, Human 2 Proctectomy 2 Indocyanine Green 2 Ileostomy 2 Esophagectomy 2 Colectomy 2 Bioseal 2 obsidian 1 Water 1 Tobramycin 1 Tissue Adhesives 1 Surgical Procedures, Operative 1 Surgical Fixation Devices 1 Stents 1 Somatostatin 1 Sodium Chloride 1 Saline Solution 1 Robotic Surgical Procedures 1 Proctoscopy 1 Neomycin 1 Neoadjuvant Therapy 1 Negative-Pressure Wound Therapy 1 Mortality 1 Metronidazole 1 Marital Status 1 Laparotomy 1 Inulin 1 Hematologic Tests 1 Fibrin Tissue Adhesive 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Anastomotic Leak × Saline Solution × Clear all

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon ⚡